Skip to main content
Premium Trial:

Request an Annual Quote

Anja Kammesheidt

Pathway Genomics has named Anja Kammesheidt its vice president of research and development. She joins the firm from Agendia where she worked on genomics-based personalized diagnostics and directed translational science projects. Prior to that, she served as chief scientific officer at Ambry Genetics for 10 years.

Kammesheidt received her bachelor and doctoral degrees in biological sciences from the University of California, Irvine, with a focus on molecular neurobiology. After completing her postdoctoral training at the University of California, San Diego, she joined Purdue Pharma as a research scientist focused on neuropathic pain targets.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.